Indian, German firms to collaborate on immunoglobulin products: Indian Embassy
Indian firm VINS Bioproducts and Germany's Neovii Biotech have signed an agreement to collaborate on the manufacturing and commercialization of immunoglobulin products. The partnership includes technology transfer to India to support organ transplantation and blood disorder treatments.
Why it matters
This collaboration aims to enhance India's domestic manufacturing capabilities for specialized biological drugs and reduce import dependency.
Indian, German firms to collaborate on immunoglobulin products: Indian Embassy The Indian mission facilitated the exchange of a non-disclosure agreement (NDA) between Germany's Neovii Biotech GmbH and India's VINS Bioproducts Ltd. on the sidelines of the Indo-German Health Leadership Dialogue on October 13, says Embassy of India in Berlin London An Indian and a German company will collaborate on the manufacturing and commercialisation of immunoglobulin products, including a drug used in organ transplantation, with technology transfer to India, the Embassy of India in Berlin has said. The Indian mission facilitated the exchange of a non-disclosure agreement (NDA) between Germany's Neovii Biotech GmbH and India's VINS Bioproducts Ltd. on the sidelines of the Indo-German Health Leadership Dialogue on October 13, it said.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in